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Abstract
Background: Childhood overweight and obesity remains high, contributing to cardiometabolic risk factors at younger
ages. It is unclear which measures of adiposity serve as the best proxies for identifying children at metabolic risk. This
study assessed whether DXA-derived direct measures of adiposity are more strongly related to cardiometabolic risk
factors in children than indirect measures.
Methods: Anthropometric and DXA measures of adiposity and a comprehensive assessment of cardiometabolic risk
factors were obtained in 288, 9–12 year old girls, most being of Hispanic ethnicity. Multiple regression models for each
metabolic parameter were run against each adiposity measure while controlling for maturation and ethnicity.
In addition, regression models including both indirect and direct measures were developed to assess whether
using direct measures of adiposity could provide a better prediction of the cardiometabolic risk factors beyond that of
using indirect measures alone.
Results: Measures of adiposity were significantly correlated with cardiometabolic risk factors (p < 0.05) except fasting
glucose. After adjusting for maturation and ethnicity, indirect measures of adiposity accounted for 29-34% in
HOMA-IR, 10-13% in TG, 14-17% in HDL-C, and 5-8% in LDL-C while direct measures accounted for 29-34% in
HOMA-IR, 10-12% in TG, 13-16% in HDL-C, and 5-6% in LDL-C. The addition of direct measures of adiposity to
indirect measures added significantly to the variance explained for HOMA-IR (p = 0.04).
Conclusion: Anthropometric measures may perform as well as the more precise direct DXA-derived measures of
adiposity for assessing most CVD risk factors in preadolescent girls. The use of DXA-derived adiposity measures
together with indirect measures may be advantageous for predicting insulin resistance risk.
Trial registration: NCT02654262. Retrospectively registered 11 January 2016.
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Background
With the rising prevalence of childhood obesity and its
associated increased risk for developing metabolic ab-
normalities, type 2 diabetes and cardiovascular disease
(CVD), having a measure of adiposity that is accurate
and sensitive for predicting CVD risk in children is
essential [1]. Currently, the most commonly used index
to assess adiposity and identify individuals at cardio-
metabolic risk is BMI [2]. Although BMI is an easy index
to calculate, it does not differentiate between fat and lean
tissue masses [3]. Body fat is more associated with meta-
bolic abnormalities than lean body mass [4]. In children,
fat mass and lean mass increase at different proportions
depending on pubertal status, making the use of BMI to
assess adiposity in children difficult [5]. Indeed, BMI has
been shown to have low sensitivity for identifying children
at risk for health related problems, with 38% of BMI-
defined obese children not having metabolic syndrome
(MetS) [6, 7]. This leads to the question as to whether
BMI is an adequate measure for assessing adiposity in
children and if it should continue to be used as a tool for
risk stratification.
Waist circumference (WC) is another common indirect
measure of adiposity. Unlike BMI, which is a proxy
measure for total body adiposity, WC is an indicator of
abdominal adiposity [2]. In adults, it is clear that the
central distribution of body fat, particularly visceral
adipose tissue, is associated with metabolic impairment
and thus is an important measure for predicting risk in
adults [6]. However, the relationship between visceral
fat and cardiometabolic risk in children may differ from
that of adults [8]. In addition, the accuracy of using
WC to predict CVD risk in children is complicated by
their large variation in growth rates. The height of
children of similar age and sex can vary by up to ~28 cm
[9]. In adults with the same WC, taller individuals have
less metabolic risk than shorter individuals. Hence, the
use of waist-to-height ratio (WHtR) for predicting risk in
children has been suggested in order to control for the
height variablility [9]. Whether WHtR is superior to other
adiposity measures for assessing cardiometabolic risk in
children is unclear [10].
With the development of imaging methods, total and
regional adiposity can now be more accurately and
precisely measured. Dual-energy X-ray absorptiometry
(DXA) is considered a gold standard for body fat assess-
ment [2]. Unlike the anthropometric measures of adi-
posity, DXA is able to discriminate between fat mass
and lean mass [11]. However, it is costly and involves
exposure to radiation making the use of simpler indirect
methods of adiposity assessment more feasible for clinical
and epidemiological settings. Despite DXA’s ability to
accurately measure adiposity, whether it is superior
to indirect measures for identifying children with
cardiometabolic risk is unclear. Therefore, the aim of
this study was to assess whether direct DXA-derived
measures of total and regional adiposity are more
strongly related to cardiometabolic risk factors in
children than common indirect measures.
Methods
Study population
Two-hundred eighty-eight girls aged 9–12 were re-
cruited from local schools, pediatric clinics, and wellness
community events in Tucson, Arizona as participants in
the “Soft Tissue and Bone Development in Young Girls
(STAR)” study, designed to assess the effects of adiposity
and related metabolic risk factors on bone development.
Exclusion criteria included: diagnosis of diabetes, taking
any medications that alter body composition, physical
disability that limits physical activity, and learning
disability that limited completion of questionnaires or
otherwise made the participant unable to comply with
assessment protocols. The study protocol was approved
by the University of Arizona Human Subjects Protection
Committee. Written informed consent was obtained
from all participants and their parents or legal guardians.
Once enrolled, the girls were scheduled to come to the
Body Composition Research Laboratory at the University
of Arizona where all body composition measurements,
blood draw, and questionnaires were completed.
Anthropometric measures
Anthropometric measures were obtained according to
standardized protocols [12]. Body mass was measured to
the nearest 0.1 kg using a calibrated scale (Seca, Model
881, Hamburg, Germany) and height was measured at
full inhalation to the nearest mm using a stadiometer
(Shorr Height Measuring Board, Olney, MD). Using a
flexible tape and with the subjects standing, waist
circumference (WC) was measured at the umbilicus in
cm. The mean of two measurements was used for each
anthropometric variable. Measurements were repeated if
they differed by ≥0.3 kg for body mass and ≥0.5 cm for
height and ≥1 cm for WC. If repeat measures were re-
quired, the mean of the second set of measures was used
[13]. BMI was calculated as weight (kg) divided by
height (m) squared. Based on CDC growth charts, BMI
percentiles specific for age and gender were used to
categorize girls as either normal weight (≥5th and <85th
percentiles), overweight (≥85th and <95th percentiles),
or obese (≥95th percentile) [14]. WHtR was calculated
as WC (cm) divided by height (cm). Maturity offset was
estimated from age and anthropometric measures
(height, weight, sitting height, and leg length) using the
Mirwald equation [15]. Maturity offset, an estimate of
years to peak height velocity, is strongly related to skeletal
maturation [15].
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DXA adiposity measures
Measures of whole-body (total fat mass, total percent fat)
and regional adiposity (android fat mass) were obtained
from dual energy x-ray absorptiometry (DXA) using a GE/
Lunar Radiation Corp (Madison, WI) Prodigy following
standard subject positioning and data acquisition proto-
cols. The android region is the area extending vertically
from immediately superior to the iliac crests to 20% of the
distance between this point and immediately below the
chin, and laterally to include all of the torso. The within-
subject variation for bone and soft tissue in our laboratory
on the Lunar Prodigy machine has been previously
reported [16, 17]. The DXA was calibrated daily according
to manufacturer guidelines. DXA scan analyses were per-
formed by one certified technician. Fat mass index (FMI)
was calculated from DXA-derived total body fat mass in
kilograms divided by the square of height in meters ((kg)/
height2 (m)).
Metabolic measures
Fasting blood samples were drawn by venipuncture and
centrifuged after sitting for a minimum of 30 min and no
longer than 45 min at room temperature to allow for
clotting. Serum was separated and aliquoted into cryovials,
and either immediately sent for analysis or stored at -80 °C
for later analyses. Fasting glucose and lipids were measured
by CLIA certified clinical laboratory immediately post-
processing. Fasting glucose was measured in serum utilizing
a clinical laboratory hexokinase-based automated assay
with intra- and inter-assay variability of 3.22 and 0.54%,
respectively. Total fasting triglycerides were measured in
serum with an automated enzymatic method using a modi-
fied Trinder reaction. The intra- and inter-assay variability
were 2.85% and 0.48%, respectively. Total fasting high
density lipoprotein cholesterol (HDL-C), and low density
lipoprotein cholesterol (LDL-C) were measured in serum
with an automated enzymatic assay utilizing a homoge-
neous method. Intra- and inter-assay variability for HDL-C
were 4.12 and 1.25% and for LDL-C were 5.61 and 0.46%.
Using stored serum samples, fasting insulin was measured
in the laboratory at the University of Arizona utilizing a
human insulin specific RIA that does not cross-react with
pro-insulin (EMD Millipore, Darmstadt, Germany). The
intra- and inter-assay variability were 2.9 and 7.5%, re-
spectively. If any intra-assay difference between duplicates
was >10%, the sample was reanalyzed. Insulin resistance
was estimated using a homeostatic model assessment of
insulin resistance (HOMA- IR), with the following cal-
culation: HOMA-IR = (insulin [μU/L] × glucose [mM/
L])/22.5 [18].
Statistical Analysis
Descriptive statistics were calculated to describe the rele-
vant characteristics of the sample. Descriptive statistics are
presented as means ± standard deviations (SD) for nor-
mally distributed measures and as median (25th and
75th percentiles) for skewed variables. Bivariate rela-
tionships between each indirect adiposity measure and
each direct measure were estimated using Pearson’s
correlation coefficient and the Spearman rank order
correlation coefficient. All correlations were adjusted
using a Bonferroni-corrected p-value.
Multiple linear regression was used to examine associa-
tions of each of the adiposity measurements with cardio-
metabolic risk factors adjusting for relevant covariates. Six
regression models were run for each metabolic parameter.
Each model included a single measure of either total or
regional body fat to avoid the potential for collinearity as all
the body fat measures were strongly inter-correlated.
Pearson’s correlations were calculated between poten-
tial covariates and each of the metabolic risk indices.
Covariates with the highest correlation were included
in the regression models in addition to ethnicity, which
was included a priori. All models were checked for
linearity, normality, and homoscedasticity and appro-
priate transformations were performed if one or more
of these linear regression assumptions were not met.
Partial correlations were used to compare the degree of
association between the body fat measures and each of
the metabolic risk factors after controlling for potential
confounders. Ninety-five percent confidence intervals
(CI’s) were calculated for each partial correlation coeffi-
cient. The squared partial correleation was used to as-
sess the proportion of variance in each metabolic risk
factor that was explained by the adiposity measures
after adjusting for the other covariates in the regression
models. Although we included ethnicity as a covariate
in all our models, for a sensitivity analysis, we refit the
regression models including only girls who were of
Hispanic ethnicity in order to examine if the relationships
between the body fat measures and each of the metabolic
risk factors differed from the whole study population.
Also, for further analysis, we tested whether scaling total
percent body fat and android fat by height could increase
their individual association with each risk factor.
To assess whether using direct measures of adiposity
could provide a better prediction of the cardiometabolic
risk factors beyond that of using indirect measures
alone, multiple regression models that included all adi-
posity measures (ie. direct and indirect combined) were
developed for each of the cardiometabolic risk factors. A
Wald test was performed to test whether the set of
direct adiposity measures significantly contributed to the
prediction model. For further analysis, a separate regres-
sion model for the addition of direct measures of whole
body adiposity (FMI, total % fat) to an indirect whole
body measure (BMI) were performed against each meta-
bolic factor to assess if the addition of whole body direct
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measures to whole body indirect measures of adiposity
added significantly to the overall variance in the meta-
bolic risk factors beyond that explained by indirectly
assessed whole body adiposity. Similar regression models
were made for the addition of the direct measure of
regional adiposity (android fat mass) to indirect regional
measures (WC, WHtR).
To assess if the amount of variance in each of the
metabolic risk factors explained by the combination of
whole body adiposity measures differed when using
indirect vs. direct measurement methods, the adjusted
R2 from regression models with an indirect whole body
adiposity measure (BMI) were compared to the adjusted
R2 of models with a direct measure of whole body adi-
posity (total % fat). Similarly, to assess if the amount of
variance in each of the metabolic risk factors explained
by the combination of regional adiposity measures differed
when using indirect vs. direct measurement methods, the
adjusted R2 from regression models with an indirect re-
gional adiposity measure (WC or WHtR) were compared
to the adjusted R2 of models with an indirect measure of
regional adiposity (android fat mass). Partial correlation
coefficients of the regional and whole body measures in
the previously described models were compared to assess
whether whole body measures of adiposity had greater as-
sociations with the metabolic risk factors than regional
measures. As there was a high potential for collinearity,
the variance inflation factors (VIF) were calculated for all
models including multiple adiposity measures.
A p-value of <0.05 was considered statistically significant.
All analyses were performed using STATA version 13.1.
Results
Of the 288 girls recruited for the study, 269 girls had
complete data for all variables and were used in the final
analyses except for regression models with HOMA-IR
for which 234 girls made up the total sample due to
study budgetary constraints for measuring fasting insulin
levels. Similar results were found when regression ana-
lyses were run on other risk factors based on 269 or 234
girls. Sample descriptive statistics are given in Table 1.
All variables are presented in their original units. The
cardiometabolic parameters (except for fasting glucose),
WC, WHtR, FMI and Android fat, were not normally
distributed and were log-transformed for linear regres-
sion analyses. The majority (76%) of the sample reported
Hispanic ethnicity. Based on U.S. National Center for
Health Statistics/Centers for Disease Control and Pre-
vention percentiles for body mass index (BMI, kg/m2),
59% of girls were normal weight (BMI 5th–85th percentile),
18% were overweight (BMI 85th–95th percentile), and 23%
were obese (BMI >95th percentile) [19].
Pairwise correlation coefficients between the indirect
and direct measures of body fat are given in Table 2. All
adiposity measures were strongly inter-correlated. BMI-
percentile, BMI category (normal weight, overweight, and
obese), and BMI were most strongly correlated with FMI.
WC was most strongly correlated with DXA Android fat
mass whereas WHtR had a stronger correlation with DXA
total body % fat and FMI, both of which are measures of
total adiposity rather than regional adiposity.
Table 1 Participant characteristics
Characteristic Mean ± SD
Age (years) 10.8 ± 1.1
Ethnicity
Hispanic or Latino 205 (76.2%)
Not Hispanic or Latino 64 (23.8%)
Weight (kg) 41.9 (33.6–53.2)b
Height (cm) 146.0 ± 9.6
BMI Percentile
Normal (<85th) 159 (59.1%)
Overweight (≥85th < 95th) 47 (17.5%)
Obese (≥95th) 63 (23.4%)
WC (cm) 73.3 (64.1–84.0)b
WHtR 0.5 (0.4–0.6)b
Body fat, % 32.4 ± 10.0
FMI (kg/m2) 6.1 (3.9–9.2)b
Android fat mass (kg) 0.9 (0.5–1.7)b
Fasting Glucose (mg/dL) 92.9 ± 6.8
Fasting Insulin (μU/mL)a 17.8 (13.3–23.9)b
HOMA-IRa 4.0 (3.0–5.6)b
TG (mg/dL) 90.0 (69–126)b
HDL (mg/dL) 50.0 (45–58)b
LDL (mg/dL) 97.0 (83–119)b
WC waist circumference (cm), WHtR waist-to-height-ratio, FMI fat mass index
(kg/m2), HOMA-IR homeostatic model assessment of insulin resistance, TG
triglycerides, HDL-C high density lipoprotein cholesterol (mg/dL), LDL-C
low density cholesterol (mg/dL)
an = 234
bmedian (range- 25th percentile to 75th percentile)
Table 2 Pairwise correlation coefficients among direct and
indirect adiposity measures
Indirect adiposity measure Direct adiposity measure
Total % body fat logFMI logAndroid
fat mass
BMI percentile 0.85 0.90 0.88
BMI 0.87 0.92 0.90
BMI categorya 0.84 0.87 0.85
logWC 0.89 0.92 0.94
logWHtR 0.89 0.90 0.87
WC waist circumference (cm), WHtR waist-to-height-ratio
aSpearman correlation used
n = 269
p > 0.005 for all correlations
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Results of linear regression between each adiposity
measure with the cardiometabolic risk factors are pre-
sented in Table 3. All models were adjusted for ethnicity
and maturity offset, a measure of skeletal maturation. Ad-
justment for other potential confounding factors such as
physical activity and diet did not substantially alter partial
correlations between adiposity measures and metabolic
risk factors (<0.03 change in r) and added <1% to the total
variance explained by the models (data not shown). Thus,
they were not included in the final models. In addition,
BMI categories based on established cut points [19] were
used in all regression analyses as these categories ex-
plained more of the variance in the metabolic risk factors
than BMI as a continuous variable (data not shown).
Overall, after adjusting for ethnicity and maturation, the
variances in cardiometabolic indices explained by indirect
and direct adiposity measures were similar and their par-
tial correlations fell within 95% CI’s of each other, with the
exception of the overweight BMI category, which had
weaker association with each of the metabolic factors (r =
0.32, 0.31, 0.14, -0.13, 0.09 for fasting insulin, HOMA-IR,
TG, HDL-C, and LDL-C respectively). All other indirect
measures of adiposity accounted for 30-36% of the vari-
ance in fasting insulin, 0.4-0.6% in fasting glucose, 29-34%
in HOMA-IR, 10-13% in TG, 14-17% in HDL-C, and 5-
8% in LDL-C while direct measures accounted for 30-36%
in fasting insulin, 0.6-10% in fasting glucose, 29-34% in
HOMA-IR, 10-12% in TG, 13-16% in HDL-C, and 5-6%
in LDL-C. Of the indirect measures, BMI categories had
weaker associations with each of the metabolic risk indices
compared to WC and WHtR. Compared to the normal
weight category, the obese BMI category had stronger as-
sociations with each of the metabolic indices, except fast-
ing glucose, than the overweight group (obese vs.
overweight group partial correlation for fasting insulin =
0.55 vs. 0.32, fasting glucose = 0.06 vs. 0.09, HOMA-IR =
0.54 vs. 0.31, TG= 0.28 vs. 0.14, HDL-C = -0.38 vs. -0.14,
LDL-C = 0.22 vs. 0.09). Both WC and WHtR predicted
each metabolic marker to a similar extent (WC vs. WHtR
partial correlation for fasting insulin = 0.60 vs 0.57, fasting
glucose = 0.08 vs. 0.08; HOMA-IR = 0.58 vs. 0.55, TG =
0.36 vs. 0.35, HDL-C = -0.41 vs. -0.40, LDL-C = 0.28 vs.
0.29). Of the direct measures, Android fat mass explained
more of the variance for the majority of metabolic markers
compared to total % body fat and FMI after adjusting for
maturation and ethnicity (Table 3). None of the adiposity
measures were significantly (p < 0.05) associated with fast-
ing glucose. The variances in fasting insulin accounted for
by both direct and indirect adiposity measures were simi-
lar to that of HOMA-IR (Table 3). Since HOMA-IR is
based on fasting glucose and insulin, it appears that insulin
levels drive the association of HOMA-IR with adiposity.
Scaling the adiposity measures of total % body fat and
Android fat mass by height, did not increase their ability
to predict the metabolic risk factors (data not shown)
and thus, total % body fat and Android fat mass were
used in all models. When examining the relationship be-
tween each adiposity measure and metabolic risk factor
in only girls of Hispanic ethnicity, similar partial cor-
relations and model adjusted R2’s were found as in the
full study sample (data not shown). Thus, to maximize
statistical power, results from the full sample are pre-
sented in all the tables.
To determine whether direct measures of adiposity
added to the variance explained for each metabolic risk
marker beyond that explained by indirect measures, the
adjusted R2 from models including all indirect adiposity
measures were compared to models where direct mea-
sures were added (Table 4). The addition of both whole
body and regional directly assessed adiposity measures
(total % body fat, FMI, Android fat mass) to indirect
measures (BMI, WC, WHtR) did not significantly increase
the variance in TG, HDL-C, and LDL-C explained by
indirect measures alone (p = 0.05, 0.25, and 0.50, re-
spectively). The addition of direct measures to indirect
did add significantly to the variance explained for
HOMA-IR (p = 0.04). When comparing the addition of
direct measures of whole body adiposity (total % body
fat, FMI) to the indirect measure of whole body adi-
posity (BMI), the addition of the direct measures
significantly added to the variance explained for all
metabolic indices (p = 0.002, p = 0.03, p = 0.02, p = 0.03
for HOMAIR, TG, HDL-C, LDL-C respectively).
When comparing the addition of DXA-derived an-
droid fat mass, a more precise measure of regional fat
to the indirect measures of regional adiposity (WC,
WHtR), the addition of Android fat mass added
significantly to the variance explained for HOMA-IR
(p = 0.01) but not to TG, HDL-C and LDL-C (p = 0.85,
0.21, and 0.20, respectively).
When WC or WHtR were added to a regression
model with the BMI categories along with ethnicity and
maturation, they explained similar amounts of variance
in each metabolic factor as the combination of direct
measures of total percent fat and android fat mass
(Tables 5 and 6). Further comparison of the partial re-
gression coefficients of the BMI categories and WC or
WHtR from the models showed that WC and WHtR
had higher associations with the metabolic risk factors
than the BMI categories (Table 5). Due to the presence of
collinearity (VIF > 10) when total percent fat and android
fat mass were combined in the same model, we were
unable to report meaningful partial correlation coeffi-
cients for these measures.
Discussion
The aim of this study was to determine whether direct
DXA-derived measures of total and regional adiposity
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Table 3 Partial correletions of adiposity measures with metabolic risk factors










logFasting Insulin (μU/mL)a Indirect Measures
BMI category 0.42
Overweight 0.32*** (0.20, 0.43)
Obese 0.55*** (0.45, 0.63)
logWC (cm) 0.60*** (0.51, 0.68) 0.45
logWHtR 0.57*** (0.48, 0.65) 0.42
Direct Measures
Total % body fat 0.55*** (0.45, 0.63) 0.41
logFMI (kg/m2) 0.57*** (0.48, 0.65) 0.42
logAndroid fat mass (kg) 0.60*** (0.51, 0.68) 0.45
logFasting Glucose (mg/dL)b Indirect Measures
BMI category 0.06
Overweight 0.09 (−0.03, 0.21)
Obese 0.06 (−0.06, 0.18)
logWC (cm) 0.08 (−0.04, 0.20) 0.06
logWHtR 0.08 (−0.04, 0.20) 0.06
Direct Measures
Total % body fat 0.09 (−0.03, 0.21) 0.06
logFMI (kg/m2) 0.08 (−0.04, 0.20) 0.06
logAndroid fat mass (kg) 0.10 (−0.02, 0.22) 0.07
logHOMA-IRb Indirect Measures
BMI category 0.41
Overweight 0.31*** (0.19, 0.42)
Obese 0.54*** (0.44, 0.63)
logWC (cm) 0.58*** (0.49, 0.66) 0.44
logWHtR 0.55*** (0.45, 0.63) 0.42
Direct Measures
Total % body fat 0.54*** (0.44, 0.63) 0.41
logFMI (kg/m2) 0.55*** (0.45, 0.63) 0.42
logAndroid fat mass (kg) 0.58*** (0.49, 0.66) 0.45
logTG (mg/dL)b Indirect Measures
BMI category 0.12
Overweight 0.14* (0.02, 0.26)
Obese 0.28*** (0.17, 0.39)
logWC (cm) 0.36 *** (0.25, 0.46) 0.17
logWHtR 0.35 *** (0.24, 0.45) 0.16
Direct Measures
Total % body fat 0.28*** (0.17, 0.39) 0.12
logFMI (kg/m2) 0.31*** (0.20, 0.41) 0.13
logAndroid fat mass (kg) 0.34*** (0.23, 0.44) 0.15
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are more strongly related to cardiometabolic risk factors
in children than common indirect measures. Our results
showed that after adjusting for maturation and ethnicity
direct and indirect measures of adiposity explained simi-
lar amounts of variance in each of the cardiometabolic
risk factors with the variance explained being highest for
HOMA-IR and fasting insulin and relatively low for TG,
HDL-C, LDL-C, and fasting glucose. Considering that
the adiposity measures, both direct and indirect, were
substantially intercorrelated, the similarities in variance in
each metabolic risk factor explained by the measures of
adiposity are not surprising. These results suggest there is
little to gain by having direct measures of adiposity when
it comes to assessing cardiometabolic risk. Similar results
were reported by Steinberger et al. who compared BMI
and skinfolds to DXA-derived measures of adiposity and
the relation of these measures to cardiovascular risk in
adolescent boys and girls [20]. That study found that both
the indirect anthropometric measures and DXA adiposity
measures correlated similarly and to the same magnitude
to TG, HDL-C, fasting insulin, and glucose utilization
with the strongest relationship occurring in the later 2
metabolic risk indices [20]. Thus, although both indirect
and direct adiposity measures can equally predict meta-
bolic risk factors, the degree of relationship differs de-
pending on the specific risk factor being assessed. For
instance, the highest amount of variance explained by
both the indirect and direct adiposity measures were for
fasting insulin and HOMA-IR. This is consistent with pre-
vious research, which suggests a strong link between adi-
posity, insulin signaling, and the development of insulin
resistance [21]. Even though HOMA-IR is based on both
fasting insulin and glucose (insulin [μU/L] × glucose
[mM/L])/22.5), it appears that the association of adiposity
with HOMA-IR is mostly driven by fasting insulin since
there were no significant correlations between the adipos-
ity measures and fasting glucose levels in our sample
where the majority had glucose values within the normal
range. This is not surprising since fasting glucose is main-
tained within a narrow range with little variation whereas
there can be up to a 53-fold variation in fasting insulin
values in children [22]. This leaves values of insulin to out-
weigh values of glucose and be the major determinant of
their combined effect in HOMA-IR [22, 23]. Overall, our
Table 3 Partial correletions of adiposity measures with metabolic risk factors (Continued)




logWC (cm) −0.41*** (−0.51,−0.30) 0.20
logWHtR −0.40 *** (−0.50,−0.29) 0.19
Direct Measures
Total % body fat −0.36*** (−0.46,−0.25) 0.16
logFMI (kg/m2) −0.39*** (−0.49,−0.28) 0.18
logAndroid fat mass (kg) −0.40*** (−0.50,−0.29) 0.19
logLDL (mg/dL)b Indirect Measures
BMI category 0.04
Overweight 0.09 (−0.03, 0.21)
Obese 0.22** (0.10, 0.33)
logWC (cm) 0.28*** (0.17, 0.39) 0.07
logWHtR 0.29*** (0.18, 0.40) 0.08
Direct Measures
Total % body fat 0.23** (0.11, 0.34) 0.05
logFMI (kg/m2) 0.25*** (0.13, 0.36) 0.05
logAndroid fat mass (kg) 0.23*** (0.11, 0.34) 0.05
All models adjusted for ethnicity and maturity offset
WC waist circumference (cm), WHtR waist-to-height-ratio, FMI fat mass index (kg/m2), HOMA-IR homeostatic model assessment of insulin resistance, TG triglycerides,
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results indicate that a high percentage of variance in in-
sulin levels and in turn HOMA-IR can be explained by
changes in adiposity. Besides adiposity, there are other
factors that could be influencing levels of the metabolic
markers. For instance, it has been shown that LDL-C
has a large genetic component contributing to its vari-
ation as is also true of HDL-C, with heritability esti-
mates of 40–60% [24]. This might partially explain why
we found the indirect and direct adiposity markers to
explain lower amounts of variance in TG, HDL-C, and
LDL-C within our sample of girls.
When assessing a combination of indirect measures
(BMI, WC, and WHtR) instead of each measure indi-
vidually, we found that the combination of indirect mea-
sures explained a high proportion of the variance in the
metabolic risk factors and that the addition of direct
measures did not increase the variance explained for
TG, HDL-C, and LDL-C levels beyond that of the
combined indirect measures. However, having more pre-
cise DXA-measurements of adiposity did increase the
amount of variance explained for HOMA-IR beyond
that of what could be explained with just the combin-
ation of indirect measures. It is possible that body fat
more directly influences changes in insulin sensitivity,
whereas high triglyceride and cholesterol levels are a
byproduct of insulin resistance. Previous studies have
demonstrated in selected subgroups that it is insulin
resistance and not the excess adiposity per se associated
with obesity that is connected with lower HDL-C and
higher triglyceride [25]. Insulin resistance at the adipo-
cyte results in increased release of free fatty acids which
in turn stimulates the assembly and secretion of VLDL
from the liver resulting in hypertriglyceridemia leading
to low HDL-C and increased small dense LDL particles
[26]. Hence, fat appears to be a direct factor contributing
to insulin resistance, whereas adiposity effects circulating
levels of lipids, particularly TG and HDL-C, indirectly
via it’s influence on insulin resistance.
The utility of BMI for assessing adiposity and predicting
cardiovascular risk factors in children has been questioned
as this age group is growing and changes in BMI can
reflect increases in lean mass more than fat mass [27]. In
the current study we found that relative to normal weight,
the BMI overweight category explained the least amount
of variance in each of the metabolic risk factors among all
the indirect and direct adiposity measures we examined
compared to the obese group. Thus, the obese category
appears to be the main contributor to the relationship
between BMI and metabolic risk factors. Ado et al. also
found that BMI in general performed weaker at estimating
HOMA-IR, TG, and total cholesterol relative to DXA-
measured total percent fat in U.S. children aged 12–18
[28]. When we added the DXA-derived whole body mea-
sures of total percent body fat and FMI to BMI, the
Table 4 Variance (adjusted R2) in metabolic risk markers explained by all indirect adiposity measures compared to all indirect and
direct adiposity measures combined
Measures of Total and
Regional Adiposity
Indirect : BMI category,
logWC, logWHtR
Indirect + Direct: BMI category,
logWC, logWHtR + total% body
fat, logFMI, logAndroid fat mass
Significance of adding one
or more direct measures
logHOMA-IR 0.45 0.46 P = 0.04
logTG 0.14 0.16 P = 0.05
logHDL 0.18 0.18 P = 0.25
logLDL 0.09 0.08 P = 0.50
Measures of Total body adiposity Indirect: BMI category Indirect + Direct: BMI category +
total % body fat, logFMI
logHOMA-IR 0.41 0.44 P = 0.002
logTG 0.09 0.11 P = 0.03
logHDL 0.15 0.18 P = 0.02
logLDL 0.04 0.06 P = 0.03
Measures of Regional adiposity Indirect: logWC, logWHtR Indirect + Direct: logWC, logWHtR
+ logAndroid fat mass
logHOMA-IR 0.44 0.46 P = 0.01
logTG 0.14 0.14 P = 0.85
logHDL 0.17 0.18 P = 0.21
logLDL 0.08 0.09 P = 0.20
WC waist circumference (cm), WHtR waist-to-height-ratio, FMI fat mass index (kg/m2), HOMA-IR homeostatic model assessment of insulin resistance, TG triglycerides, HDL-C
high density lipoprotein cholesterol (mg/dL), LDL-C low density cholesterol (mg/dL)
All models adjusted for ethnicity and maturity offset
n = 234 for all models
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variance explained for HOMA-IR, TG, HDL-C, and LDL-
C levels significantly increased. Likewise, Lawlor et al.
found that adding other adiposity measurements to a
model with BMI increased the ability to predict risk com-
pared with BMI alone [27].
WC and WHtR have been proposed as being useful
indicators of metabolic risk since these measures poten-
tially reflect the regional distribution of fat in the abdo-
men, which in adults has been shown to relate to
abnormal cardiometabolic risk factors more strongly
than measures of general adiposity [29]. In our study, we
found that both WC and WHtR explained more variance
in each of the metabolic risk factors than BMI categories
and were comparable in magnitude to the DXA-derived
measures of regional and whole body fat. This is con-
trary to the findings of Freedman et al. who reported
that BMI related similarly to CVD risk factors as other
indirect and direct measures of body fat in US children
[30]. We also found that when WC or WHtR were com-
bined with BMI, both WC and WHtR accounted for
greater proportions of the variance in the metabolic risk
factors than the BMI categories. These findings are simi-
lar to those of Wolfgram et al. who found that WC cor-
related more strongly than BMI Z-score and to a similar
magnitude as MRI-derived adiposity measures with
HOMA-IR, TG, and HDL-C in non-obese female ado-
lescent girls of varying ethnicities [31]. Overall, we con-
clude that indirect regional adiposity measures of WC
and WHtR are strongly related to cardiometabolic risk
factors in preadolescent girls with no superiority of
WHtR over WC. In addition there appears to be no added
benefit of having a more direct measure of abdominal adi-
posity for explaining the variance of metabolic risk indices.
The present study has several strengths. First, we had
a relatively large sample of preadolescent girls within a
narrow age range and wide range of body fat levels,
which allowed for the relationships between fat
Table 6 Adjusted R2 values for regression of total percent body
fat and logAndroid fat mass on metabolic risk factors
%total body fat + logAndroid fat mass





All models adjusted for ethnicity and maturity offset
HOMA-IR homeostatic model assessment of insulin resistance, TG triglycerides,
HDL-C high density lipoprotein cholesterol (mg/dL), LDL-C low density
cholesterol (mg/dL)
Table 5 Partial correlation coefficients and adjusted R2 values for regression of BMI categories with either the addition of logWC or
logWHtR with metabolic risk factors





























All models adjusted for ethnicity and maturity offset
WC waist circumference (cm), WHtR waist-to-height-ratio, FMI fat mass index (kg/m2), HOMA-IR homeostatic model assessment of insulin resistance, TG
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measures and metabolic risk factors to be determined
for a range of body fat without the added confounding
effects of gender and age. In addition, we were able to
better examine the relationship between the adiposity
measures and cardiometabolic factors by controlling for
other variables potentially influencing this relationship
such as maturation, ethnicity, physical activity, and diet,
although in our analyses we found physical activity and
diet did not significantly influence the associations be-
tween adiposity measures and metabolic risk. Our study
adds to the literature examining the association of indirect
vs. direct measures of adiposity to cardiometabolic risk as
our sample was approximately 80% Hispanic. Few previ-
ous studies have focused on Hispanic children, who have
been reported to have higher rates of obesity, metabolic
syndrome, and diabetes than their non-Hispanic peers [2,
32]. In a sub-analysis of data on Mexican American chil-
dren aged 12–19 from the National Health and Nutrition
Examination Survey 1999–2004, Cui et al. found that
whole body adiposity measures, BMI, total percent fat,
and FMI were similarly correlated with cardiovascular risk
factors with the exception of fasting insulin for which BMI
had a stronger relationship [11]. The regional adiposity
measures of WC, WHtR, and DXA percent trunk fat, did
not significantly differ in their relationship with metabolic
risk factors [11]. Our study extends Cui’s findings to
Hispanic girls of younger age showing that anthropo-
metric methods were comparable to DXA adiposity
measures when assessing metabolic risk. We found no
advantage of BMI over DXA measures for assessing
fasting insulin, which could indicate that certain mea-
sures of adiposity may be better at accessing certain
metabolic indices in different age groups.
Since the data for this analysis were cross-sectional,
we could not address whether direct measures of adipos-
ity have added value over indirect in determining meta-
bolic risk factors as children progress through puberty
and into adulthood, a time when fat patterning and dis-
tribution undergo large changes [33]. Future studies are
needed to examine if indirect measures of adiposity are
adequate enough to capture these changes in adiposity
depots, which may reflect changes in metabolic risk fac-
tors. In addition, the lipid levels of our study sample
were essentially normal, with >80% of the girls falling
below the NCEP recommended cut-off for high lipid
levels in children [34]. Future research is needed to
assess whether direct measures may be advantageous
beyond using indirect measures in children with dys-
lipidemia. A possible limitation of our analysis is the
categorization of BMI into normal weight, overweight,
and obese groups instead of using BMI as a continuous
predictor in our regression models. Such categorization of
continuous predictors in linear regression can lead to loss
of information and power [35]. However, we found
that the categorization of BMI based on established
cut points [19] explained more of the variance in the
metabolic risk factors than BMI as a continuous
variable.
Conclusions
When it comes to assessing metabolic risk in preadolescent
girls, anthropometric measures appear to perform just as
well as the more precise direct DXA-derived measures. Out
of the anthropometric adiposity measures, WC and WHtR,
which perform similarly, are superior to the use of BMI
categories for explaining variance in metabolic risk factors.
When used in combination there is little additional gain of
having direct measures over these indirect measures
for identifying metabolic risk factors. However, the use
of DXA-derived adiposity measures with indirect mea-
sures may be advantageous in the assessment of insulin
resistance. Although anthropometric dimensions do not
give a precise quantification of whole body or regional fat,
these surrogate measures are no less associated with
cardiometabolic outcomes than direct measures and thus
can be reliably used for determining adverse metabolic
risk profiles.
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